Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV002474414 | SCV002771000 | uncertain significance | not provided | 2023-04-04 | criteria provided, single submitter | clinical testing | Available data are insufficient to determine the clinical significance of the variant at this time. The frequency of this variant in the general population is uninformative in assessment of its pathogenicity (http://gnomad.broadinstitute.org). Computational tools disagree on the variant's effect on normal protein function. |
Labcorp Genetics |
RCV002574697 | SCV003467248 | likely benign | Spastic paraplegia | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004673679 | SCV005158989 | uncertain significance | Inborn genetic diseases | 2024-06-16 | criteria provided, single submitter | clinical testing | The c.5188A>C (p.S1730R) alteration is located in exon 10 (coding exon 9) of the SACS gene. This alteration results from a A to C substitution at nucleotide position 5188, causing the serine (S) at amino acid position 1730 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Gene |
RCV002474414 | SCV005626727 | uncertain significance | not provided | 2024-06-27 | criteria provided, single submitter | clinical testing | In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |